Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00354835 · OUTCOME

Compare Event Free Survival (EFS) With Respect to the Level of % Change in FDG PET Maximum Standard Uptake Value (SUVmax) at Week 15

Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma · Source last updated 2023-01-31

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
Probability
Interval / dispersion
95% Confidence Interval
Time frame
4 years

What was measured

4-year EFS (probability of no relapse, secondary malignancy, or death after 4 years in the study)

Analysis population: 421 participants were excluded due to ineligibility or absence of SUVmax evaluation at baseline and week 15.

Groups in this outcome

% Change in SUVmax From Baseline to Week 15 < 40%

Not reported

% Change in SUVmax From Baseline to Week 15 >= 40%

Not reported

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
% Change in SUVmax From Baseline to Week 15 < 40%9
% Change in SUVmax From Baseline to Week 15 >= 40%51

Reported measurements

Source class 1
Values in Probability · Interval/dispersion: 95% Confidence Interval
GroupValueSpreadLowerUpperComment
% Change in SUVmax From Baseline to Week 15 < 40%0.6667Not reported0.28951.0000Not reported
% Change in SUVmax From Baseline to Week 15 >= 40%0.5686Not reported0.43030.7070Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        0.2895
        upper Limit
        1.0000
        value
        0.6667
      2. group Id
        OG001
        lower Limit
        0.4303
        upper Limit
        0.7070
        value
        0.5686
denoms
  1. counts
    1. group Id
      OG000
      value
      9
    2. group Id
      OG001
      value
      51
    units
    Participants
description
4-year EFS (probability of no relapse, secondary malignancy, or death after 4 years in the study)
dispersion Type
95% Confidence Interval
groups
  1. id
    OG000
    title
    % Change in SUVmax From Baseline to Week 15 < 40%
  2. id
    OG001
    title
    % Change in SUVmax From Baseline to Week 15 >= 40%
param Type
NUMBER
population Description
421 participants were excluded due to ineligibility or absence of SUVmax evaluation at baseline and week 15.
reporting Status
POSTED
time Frame
4 years
title
Compare Event Free Survival (EFS) With Respect to the Level of % Change in FDG PET Maximum Standard Uptake Value (SUVmax) at Week 15
type
SECONDARY
unit Of Measure
Probability

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice